Skip to main content

Table 1 Characteristics of study populations with stage III colon cancer eligible for adjuvant chemotherapy following surgical resection

From: Timing of adjuvant chemotherapy initiation and mortality among colon cancer patients at a safety-net health system

Characteristics

Study population for adjuvant chemotherapy initiation ≤ 8 weeks of surgical resection

(n = 222)

n (%)

Study population for adjuvant chemotherapy initiation ≤ 12 weeks of surgical resection

(n = 310)

n (%)

Age (years)

 Median (Interquartile range)

56 (50–61)

56 (50–61)

Sex

 Female

126 (57)

175 (56)

 Male

96 (43)

135 (44)

Race/Ethnicity

 Non-Hispanic White

77 (35)

112 (36)

 Non-Hispanic Black

67 (30)

87 (28)

 Hispanic

57 (26)

87 (28)

 Non-Hispanic other

21 (9.5)

24 (7.7)

Insurance coverage

 Uninsured without hospital-based medical assistance program

50 (23)

73 (24)

 Uninsured with hospital-based medical assistance program

107 (48)

137 (44)

 Insureda

65 (29)

100 (32)

Marital status

 Single

89 (40)

124 (40)

 Married

70 (32)

99 (32)

 Divorced/Separated/Widowed

63 (28)

87 (28)

Body Mass Index (BMI)

 BMI < 25

56 (25)

78 (25)

 25 ≤ BMI < 30

59 (27)

87 (28)

 BMI ≥ 30

107 (48)

145 (47)

NCI comorbidity index

 0

168 (76)

235 (76)

  > 0

54 (24)

75 (24)

Tumor grade

 Well/Moderately differentiated

191 (86)

265 (85)

 Poorly differentiated/Undifferentiated

31 (14)

45 (15)

Surgery procedure

 Partial colectomy/Segmental resection

106 (48)

143 (46)

 Subtotal/Hemicolectomy/Total colectomy

116 (52)

167 (54)

Timing of adjuvant chemotherapy initiation

 Initiation ≤ 8 weeks of surgical resection

81 (36)

N/A

 No initiation ≤ 8 weeks of surgical resection

141 (64)

N/A

 Initiation ≤ 12 weeks of surgical resection

N/A

150 (48)

 No initiation ≤ 12 weeks of surgical resection

N/A

160 (52)

  1. aCommercial or public insurance